We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MRC Technology Sells its MCRs Programme to Pfizer

News   Jun 19, 2014

 
MRC Technology Sells its MCRs Programme to Pfizer
 
 
Advertisement
 

RELATED ARTICLES

New Class of Cancer Fighting Compounds Discovered

News

A new class of anti-cancer compounds that effectively kill liver and breast cancer cells has been discovered by scientists.

READ MORE

New Catalyst for Asymmetric Synthesis of Aziridine Aids Development of Novel Drugs

News

Researchers have been able to obtain aziridine-oxazolone compounds in high yields (99%) as well as high enantioselectivity or purity (98%) using a new catalyst.

READ MORE

Antisense Therapies Developed To Counter Multidrug-Resistant Bacteria

News

A team from the University of Colorado Boulder has created a drug development platform that can produce effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE